Erratum to the FDA Briefing Document Dermatologic and Ophthalmic Drugs Advisory Committee Meeting March 9, 2015 NDA[removed], Deoxycholic acid for the improvement in the appearance of moderate to severe convexity or fullne

First Page		Document Content
		Erratum to the FDA Briefing Document Dermatologic and Ophthalmic Drugs Advisory Committee Meeting March 9, 2015 NDA[removed], Deoxycholic acid for the improvement in the appearance of moderate to severe convexity or fullne Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1.005,79 KB Share Document on Facebook